Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cheapest Mounjaro available in the UK still requires a valid prescription following a clinical assessment — there is no legal route around that. Private providers typically charge between roughly £149 and £375 per month depending on the dose, following Eli Lilly's UK list-price increase in September 2025. That range is real, but the gap between the lowest and highest quote is rarely the most useful number to compare. Mounjaro is a prescription-only medicine, which means a prescriber decides whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks, in various forms: "I've seen Mounjaro for £X elsewhere, why would I pay more?" It's a fair instinct. But for a prescription medicine, price is not the right starting metric. The right question is whether the supply is legal, genuine, and clinically supervised.
Mounjaro is a Prescription-Only Medicine. UK law requires that a qualified prescriber assesses you before it can be supplied. Any seller offering it without that step is operating outside the law, and the pens themselves may not be genuine. The MHRA has seized large volumes of counterfeit weight-loss pens (some containing insulin) and in October 2025 raided the first illicit UK site producing fake tirzepatide pens. Those products were cheap. They were also dangerous. You can report suspect sellers directly via the MHRA's Yellow Card scheme.
None of this means you should overpay. It means price should be one of several filters, not the primary one. The filters that matter first: is this a GPhC-registered pharmacy, is there a real prescriber reviewing your case, and does the quoted price include everything you actually need? If you are researching where to find the cheapest Mounjaro from a legitimate, regulated source, those questions are the right place to start.
When you see a headline price from a regulated UK provider, it should cover more than the pen. A proper private service includes the clinical consultation, the prescription itself, the medicine, and delivery. Some providers charge separately for each of those, a low headline figure can quietly become a higher total once those components are added back in.
Eli Lilly raised Mounjaro's UK list price from 1 September 2025. The highest dose's list price moved from around £122 to around £330 per four-week pen, and typical private market prices since then sit roughly between £149 and £375 per month depending on the dose and the provider. These figures are widely reported; the exact price you are offered will reflect which dose you are prescribed, which is a clinical decision, not a choice you make at checkout.
For a fuller picture of how Mounjaro is priced in the UK private market, the Mounjaro prices page breaks down the factors that move that figure up or down by dose.
Mounjaro's UK licence covers adults with a body mass index of 30 or above, or 27 or above alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes, raised cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. NICE's appraisal of tirzepatide sets additional criteria for NHS access, but private eligibility follows the licensed indication.
Importantly, BMI alone does not guarantee approval. A prescriber looks at your full medical picture: current medications, relevant history, and whether the benefits outweigh any risks for you specifically. That assessment is the part of the process that actually keeps treatment safe, and it's the part that cannot be skipped, however the price is framed. If you have noticed chest pains while taking Mounjaro, that is exactly the kind of symptom a prescriber needs to know about before treatment continues.
If you want to understand the clinical basis for these medicines before deciding anything, the tirzepatide overview and the broader Mounjaro information page cover the mechanism, the trial evidence, and what the treatment involves in practice. The NHS also publishes patient-level guidance at nhs.uk/medicines/tirzepatide.
Every pharmacy legally dispensing medicines in the UK must be registered with the General Pharmaceutical Council. That register is public and searchable. If a provider cannot be found there, stop. It takes about thirty seconds to check, and it tells you more than any price comparison does.
Beyond the register, look at the process: is there a genuine clinical consultation, identity verification, and a prescriber whose name you can see? Or is the journey from basket to checkout with no clinical step in between? The latter is a supply chain you cannot trust, regardless of price. A reputable prescriber will also be able to advise you on side effects such as Mounjaro chest pain, so you know when to seek further help and when a symptom is likely to resolve on its own.
Red flags the MHRA specifically highlights: sellers operating through social media, prices well below market rate, and medicine offered without a prescriber assessment. Seeking out a cheaper listing from an unverified source is not a saving; it is a transfer of risk onto you.
If you'd like to explore what a clinically supervised, GPhC-registered route actually looks like, starting a free consultation takes a few minutes and comes with no obligation. Our prescribers review every consultation the same day, a real clinician, not software. You can also read more about the treatment options we work with, or who we are as a service, before you decide anything.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.